|
Volumn 34, Issue 4, 2002, Pages 257-261
|
Treatment of latent syphilis in HIV-infected patients with 10 d of benzylpenicillin G benethamine: A prospective study in Maputo, Mozambique
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
BENETHAMINE PENICILLIN;
CEFTRIAXONE;
PENICILLIN G;
PROBENECID;
BENZATHINE PENICILLIN;
PENICILLIN DERIVATIVE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MIXED INFECTION;
MOZAMBIQUE;
PROSPECTIVE STUDY;
REAGIN TEST;
SIDE EFFECT;
SYMPTOMATOLOGY;
SYPHILIS;
SYPHILIS SEROLOGY;
TREATMENT FAILURE;
TREPONEMA PALLIDUM;
CHEMISTRY;
DRUG COMBINATION;
HUMAN IMMUNODEFICIENCY VIRUS;
METABOLISM;
MIDDLE AGED;
PATHOGENICITY;
PATHOLOGY;
TIME;
TREATMENT OUTCOME;
ADULT;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV;
HIV INFECTIONS;
HUMAN;
MALE;
MIDDLE AGE;
MOZAMBIQUE;
PENICILLIN G, BENZATHINE;
PENICILLINS;
SUPPORT, NON-U.S. GOV'T;
SYPHILIS, LATENT;
TIME FACTORS;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
EID: 0035985328
PISSN: 00365548
EISSN: None
Source Type: Journal
DOI: 10.1080/00365540110077380 Document Type: Article |
Times cited : (6)
|
References (29)
|